Drug Company to Share Revenues With Indigenous People Who Donated Their Genes

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

  • Related Posts

    Earnings playbook: Your guide to this week’s biggest reports, including Netflix

    It’s a short week on Wall Street, but there are major earnings reports on deck that could move the stock market.

    The ‘Make America Healthy Again’ revolution has begun. Buy these food stocks to ride out the risk

    “We believe renewed consumer attention on the role of processed foods in the public health crisis is just getting started,” said TD Cowen’s Robert Moskow.

    Leave a Reply

    Your email address will not be published. Required fields are marked *